Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

9.84
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
8.84
Today|||52-Week Range
18.48
-30.46%
Year-to-Date

Today’s Trading

Previous close9.84
Today’s openn.a.
Day’s range-- - --
Volume18,055
Average volume (3 months)1,683,627
Market cap$1.0B
Dividend yield--
Data as of 07/01/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+23.86%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book12.59

Competitors

 Today’s
change
Today’s
% change
DBVTDBV Technologies SA0.000.00%
NXTMNxStage Medical Inc0.000.00%
LXRXLexicon Pharmaceutic...0.000.00%
SGMOSangamo BioSciences ...-0.93-8.39%
Data as of 4:00pm ET, 07/01/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
James F. Oliviero
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers